rdf:type |
|
lifeskim:mentions |
umls-concept:C0005802,
umls-concept:C0021641,
umls-concept:C0030705,
umls-concept:C0205170,
umls-concept:C0332173,
umls-concept:C0332307,
umls-concept:C0439064,
umls-concept:C0441994,
umls-concept:C0443315,
umls-concept:C0549178,
umls-concept:C0574032,
umls-concept:C0907402,
umls-concept:C1533685,
umls-concept:C2587213,
umls-concept:C2827666
|
pubmed:issue |
3
|
pubmed:dateCreated |
2008-2-29
|
pubmed:abstractText |
The superiority of continuous subcutaneous insulin infusion (CSII) over multiple daily injections (MDI) with glargine is uncertain. In this randomized cross-over study, we compared CSII and MDI with glargine in patients with Type 1 diabetes well controlled with CSII. The primary end-point was glucose variability.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1464-5491
|
pubmed:author |
pubmed-author:AragonaMM,
pubmed-author:BaritussioAA,
pubmed-author:BruttomessoDD,
pubmed-author:BuhlKK,
pubmed-author:CostaSS,
pubmed-author:CrazzolaraDD,
pubmed-author:Dal PosMM,
pubmed-author:Del PratoSS,
pubmed-author:GirelliAA,
pubmed-author:IoriEE,
pubmed-author:LeporeGG,
pubmed-author:MaraiLL,
pubmed-author:TiengoAA,
pubmed-author:TrevisanRR,
pubmed-author:ValentiniUU
|
pubmed:issnType |
Electronic
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
326-32
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:18307459-Blood Glucose,
pubmed-meshheading:18307459-Diabetes Mellitus, Type 1,
pubmed-meshheading:18307459-Dose-Response Relationship, Drug,
pubmed-meshheading:18307459-Humans,
pubmed-meshheading:18307459-Hypoglycemic Agents,
pubmed-meshheading:18307459-Injections,
pubmed-meshheading:18307459-Insulin,
pubmed-meshheading:18307459-Insulin, Long-Acting,
pubmed-meshheading:18307459-Insulin Infusion Systems,
pubmed-meshheading:18307459-Patient Satisfaction,
pubmed-meshheading:18307459-Statistics as Topic
|
pubmed:year |
2008
|
pubmed:articleTitle |
In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
|
pubmed:affiliation |
Department of Clinical and Experimental Medicine, Division of Metabolic Diseases, University of Padova, Padova, Italy. daniela.bruttomesso@unipd.it
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|